The effect of nerve growth factor and antibodies to nerve growth factor on ethylnitrosourea carcinogenesis in mice.
The specific induction of neural tumors by the carcinogen, ethylnitrosourea (ENU), can be enhanced by reducing the in vivo nerve growth factor (NGF) levels in mice using IgG directed against the biologically active subunit of NGF (anti-NGF). This effect is reversible, confirming that the altered endogenous NGF levels do return to normal following injection with anti-NGF. Correspondingly, no neural tumors were observed when in vivo NGF levels were elevated by administering exogenous NGF with ENU. The higher physiological levels of NGF in control mice when compared to control rats might explain why fetal administration of ENU to rats results in a greater percentage of neural tumors. This would suggest that the long studied maturation effect that NGF has on developing neural cels of the peripheral nervous system may also influence neural oncogenesis.
D000818:Animals; D005038:Ethylnitrosourea; D005260:Female; D007074:Immunoglobulin G / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000139:chemically induced / Q000517:prevention & control; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced* / Q000517:prevention & control; D009414:Nerve Growth Factors / Q000276:immunology / Q000627:therapeutic use*; D009423:Nervous System Neoplasms / Q000139:chemically induced / Q000517:prevention & control; D009607:Nitrosourea Compounds; D014565:Urogenital Neoplasms / Q000139:chemically induced
D007074:Immunoglobulin G; D009414:Nerve Growth Factors; D009607:Nitrosourea Compounds; D005038:Ethylnitrosourea